Tag: Carter

  • Dracunculiasis eradication: intensifying surveillance amid continued zero human cases in Ethiopia and Mali

    Dracunculiasis eradication: intensifying surveillance amid continued zero human cases in Ethiopia and Mali

    A total of 54 human cases of dracunculiasis (guinea-worm disease) were reported to the World Health Organization (WHO) in 2019, with Chad reporting 48 out of the 54 cases.

    In Chad, Ethiopia, Mali and South Sudan, trained volunteers are supporting surveillance and detection of infections in domestic dogs and cats. Surveillance has been heightened, as evidenced by the increase in reports of rumoured human cases which in 2019 peaked at 108 207 out of which 106 678 were investigated within 24 hours.

    “We are working with the broader scientific community to understand the epidemiology of animal infections, mainly in dogs in Chad, where the highest number of human cases were reported in 2019,” said Dr Dieudonné Sankara, who leads WHO’s eradication and elimination team in the Department of Control of Neglected Tropical Diseases. “Interestingly, there have been no human cases in Ethiopia and Mali, and 4 human cases in South Sudan in 2019, compared with 10 in 2018.”

    In Mali, the number of animals infected with Dracunculus medinensis (the guinea-worm) has decreased from 20 animals in 2018 to 8 dogs and 1 cat in 2019. However, insecurity remains a challenge to freely accessing some endemic areas in Mali.

    Conversely, Chad reported 1935 infections in dogs and 46 in cats in 2019, an increase of 85% from 2018, and a 176% increase among humans.

    Angola reported only 1 human case in 2019. Community-based surveillance is being reinforced mainly in Cunene Province where a case was reported in 2018.

    In South Sudan, integrated surveillance activities have been carried out with the trachoma and onchocerciasis control programmes, in accordance with WHO’s recommendation that programmes collaborate, integrate and co-implement activities, whenever possible, to strengthen surveillance.

    In order to strengthen cross-border surveillance, WHO led a mission to Cameroon in November 2019 to investigate circumstances around an “imported” case in the country’s Far North Region. Discussions were held with the health authorities to establish active surveillance in all villages in the area, including training for application of temephos.[1]  

    Also, in 2019, and with the support of trained field workers, vector control was intensified to larvicide ponds and water sources in more than 400 villages, compared with 72 villages in 2018.

    In late 2019, WHO supported cross-border meetings with officials of national dracunculiasis eradication programmes from Mali, Burkina Faso and Côte d’Ivoire in West Africa; between Ethiopia and South Sudan in East Africa, and between Angola and Namibia in Southern Africa, to share experiences and plan joint surveillance activities across the borders to prevent transmission of the disease.

    The disease

    Dracunculiasis is a crippling parasitic disease caused by infection with D. medinensis, a long, thread-like worm. It is usually transmitted when people drink stagnant water contaminated with parasite-infected water fleas.

    WHO works with Member States and in partnership with The Carter Center and the United Nations Children’s Fund to support efforts to eradicate the disease. WHO provides technical guidance, works with national programmes to coordinate surveillance in dracunculiasis-free areas, and monitors and reports on the progress achieved.

    WHO is the only Organization mandated to certify countries as free of transmission of the disease following the recommendations of the International Commission for the Certification of Dracunculiasis Eradication.

    Since 1995, WHO has certified a total of 199 countries, territories and areas, including 187 Member States, as free of dracunculiasis transmission.

    [1] Temephos is a cyclopicide used to kill water fleas (cyclops) that carry the infective guinea-worm larvae.

     

    Dracunculiasis eradication: intensifying surveillance amid continued zero human cases in Ethiopia and Mali
    Read More
    https://www.who.int/news-room/detail/19-03-2020-dracunculiasis-eradication-intensifying-surveillance-amid-continued-zero-human-cases-in-ethiopia-and-mali

    Views: 0

  • Did the Power of Prayer or Pembrolizumab Cure Former President Jimmy Carter?

    [ad_1]

    Former US president Jimmy Carter announced his brain cancer has disappeared, but is it due to a miracle or a medical miracle?

    In August 2015 former President Carter had elective surgery to remove a tumor on his liver. As a part of the process a scan discovered four spots on his brain. The diagnosis was stage IV melanoma. Stage IV melanoma is a kind of cancer that starts in the cells that produce the pigment that gives your skin its color, known as melanocytes. A stage IV diagnosis means it has spread via the bloodstream, or through the lymphatic system, to other areas of the body. The American Cancer Society (ACS) estimates that approximately 76,160 cases of melanoma (also referred to as malignant melanoma) were diagnosed in the United States in 2014. While melanoma accounts for only approximately 5% of skin cancer cases, it is estimated to be responsible for the vast majority of skin cancer deaths. The prognosis is generally not good for a person diagnosed with stage IV melanoma, especially one that has spread to the liver and the brain. The overall 5-year survival rate is about 15% to 20%, depending on the age and overall health of the person. The median survival is 6-10 months. The traditional course of treatment is surgery to remove tumors, radiation therapy, chemotherapy, and more recently, clinical trials, targeted therapy and immunotherapy. However, these numbers may be changing as the newer immunotherapy and targeted therapy have led to important improvements in patient outcomes. Recently an immunotherapy treatment made the news when it arrested acute lymphoblastic leukemia, saving the life of an infant in the UK.

    Pembrolizumab breakthrough treatment

    Former President Jimmy Carter was given a new breakthrough treatment Pembrolizumab. Pembrolizumab is sold under the brand name Keytruda and was developed by Merck & Co., Inc. in the United States. In September 2014 it was one of the first immunotherapy drugs approved by the Food and Drug Administration (FDA). Instead of killing cancer cells, immunotherapy drugs are designed to boost the body's immune system to fight cancer. Pembrolizumab is a monoclonal antibody. Recent studies involving Pembrolizumab have shown the drug has increased overall survival of melanoma patients. Although the long term outlook is still unknown, it is only thought to extend survival in patients and not necessarily be a cure.

    Science Proves the Healing Power of Prayer

    It's no secret that former President Jimmy Carter is a devout man. Carter was born and raised in Plains, Georgia as a Southern Baptist. He continued his religious beliefs into adulthood. He attends church everywhere he travels, teaches Sunday school, performs missionary work and is known to pray every day. Prayer groups around the world have undoubtedly been praying for the healing of the former President, along with his family and friends. For the devout, there never has been been any question that prayer has the power to heal, but others are skeptical and want scientific proof. Current research from leading hospitals and universities across the US has shown conclusively a belief in God really is good for you, making you healthier and happier, and helping you live longer. Prayer is a practice that reaches across all religions, and even to those who do not believe in a deity. "Studies have shown prayer can prevent people from getting sick – and when they do get sick, prayer can help them get better faster," Duke University's Harold G. Koenig, MD, states. An extensive review of more than 1,500 reputable medical studies "indicates people who are more religious and pray more have better mental and physical health." And out of 125 studies that looked at the link between health and regular worship, 85 showed regular churchgoers live longer. A CNN poll arrived that 73% of Americans believe in the power of prayer. Research that primarily focused on the power of prayer in healing has almost doubled in the last decade.

    So is it possible that former President Jimmy Carter has been healed by God or by a new breakthrough drug? Maybe both.

    [ad_2]

    Source by Lisa M Manley

    Views: 0